- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 205/02 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
Patent holdings for IPC class C07D 205/02
Total number of patents in this class: 58
10-year publication summary
|
4
|
2
|
1
|
3
|
2
|
8
|
5
|
4
|
2
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3161 |
4 |
| Gilead Sciences, Inc. | 2231 |
4 |
| Vettore, LLC | 17 |
4 |
| Conopco, Inc. | 5094 |
2 |
| Boehringer Ingelheim International GmbH | 4483 |
2 |
| Abbvie Inc. | 1822 |
2 |
| Blueprint Medicines Corporation | 256 |
2 |
| West China Hospital, Sichuan University | 238 |
2 |
| Anebulo Pharmaceuticals, Inc. | 17 |
2 |
| Scinnohub Pharmaceutical Co., Ltd | 48 |
2 |
| Shanghai Jemincare Pharmaceutical Co., Ltd | 71 |
2 |
| Citrachem Corp. | 5 |
2 |
| F. Hoffmann-La Roche AG | 7815 |
1 |
| Hoffmann-La Roche Inc. | 3815 |
1 |
| Unilever PLC | 2987 |
1 |
| Unilever N.V. | 2901 |
1 |
| Abbott Laboratories | 2246 |
1 |
| President and Fellows of Harvard College | 6104 |
1 |
| University of Florida Research Foundation, Inc. | 4184 |
1 |
| Agios Pharmaceuticals, Inc | 227 |
1 |
| Other owners | 20 |